Translation Acceleration Grant

Translation Acceleration Grants


Prostate Cancer Canada (PCC) has invited applications for investigator-initiated Translation Acceleration Grants (TAG) that address a significant issue in the management of prostate cancer, with a high potential of preventing disease progression and/or improving quality of life in the short term.
 
Starting in 2014, each competition has addressed a significant issue in the management of prostate cancer. The intent of the program is not to support new discovery. Rather the grants should leverage existing knowledge and capabilities to accelerate impact without overlapping currently funded Prostate Cancer Canada and Movember Foundation initiatives.

TAG1: Aggressive vs. indolent prostate cancer
TAG2: Novel therapeutics for aggressive disease
True Nth Survivorship Grants (TAG3)
TAG4 and TAG5: Innovative approaches to manage prostate cancer
TAG6: Targeted Radionuclide Therapy


These opportunities were awarded by Prostate Cancer Canada and proudly funded in part by the Movember Foundation.
smaller-still.jpg
See Funded Project Database for information on funded grants.



Plaid for Dad


Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Honouring dad this Father’s Day the Canadian way: In plaid

TORONTO, ON – (May 8, 2018) – Plaid replaces business-casual on Friday, June 15 as hundreds of thousands of Canadians don the iconic Canadian attire all to honour dad and end prostate cancer.
More

The Finger – A tried and true method to save lives

TORONTO, CANADA (May 8, 2018) – Every day, more and more methods to detect prostate cancer are being explored, but the tried and true methods of a digital rectal examination (DRE) – where a healthcare professional inserts a gloved finger into the rectum to check for abnormalities, paired with a blood test known as the prostate-specific antigen (PSA) test – which you can get through your family doctor, are still the long-standing proven ways to save a life.
More

Landmark study links tumour evolution to prostate cancer severity

Toronto (April 19, 2018) – Findings from Canadian Prostate Cancer Genome Network (CPC-GENE) researchers and their collaborators, published today in Cell, show that the aggressiveness of an individual prostate cancer can be accurately assessed by looking at how that tumour has evolved.
More


Click here for news archive